CN111943805A - Preparation method of (R) -3-chloro-1, 2-propanediol - Google Patents
Preparation method of (R) -3-chloro-1, 2-propanediol Download PDFInfo
- Publication number
- CN111943805A CN111943805A CN202010971610.1A CN202010971610A CN111943805A CN 111943805 A CN111943805 A CN 111943805A CN 202010971610 A CN202010971610 A CN 202010971610A CN 111943805 A CN111943805 A CN 111943805A
- Authority
- CN
- China
- Prior art keywords
- chloro
- reaction
- propanediol
- epoxypropane
- completed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SSZWWUDQMAHNAQ-VKHMYHEASA-N (R)-3-chloro-1,2-propanediol Chemical compound OC[C@@H](O)CCl SSZWWUDQMAHNAQ-VKHMYHEASA-N 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 38
- 238000003756 stirring Methods 0.000 claims abstract description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011259 mixed solution Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 10
- OWXJKYNZGFSVRC-NSCUHMNNSA-N (e)-1-chloroprop-1-ene Chemical compound C\C=C\Cl OWXJKYNZGFSVRC-NSCUHMNNSA-N 0.000 claims abstract description 8
- 239000003444 phase transfer catalyst Substances 0.000 claims abstract description 6
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 5
- 239000011541 reaction mixture Substances 0.000 claims abstract description 3
- 238000004821 distillation Methods 0.000 claims abstract 4
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 claims description 18
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 claims description 13
- 239000007810 chemical reaction solvent Substances 0.000 claims description 5
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical group OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- YSAVZVORKRDODB-UHFFFAOYSA-N Diethyl tartrate Chemical compound CCOC(=O)C(O)C(O)C(=O)OCC YSAVZVORKRDODB-UHFFFAOYSA-N 0.000 claims 3
- 238000004128 high performance liquid chromatography Methods 0.000 claims 2
- 238000012544 monitoring process Methods 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000005194 fractionation Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 6
- PXDRFTPXHTVDFR-UHFFFAOYSA-N propane;titanium(4+) Chemical compound [Ti+4].C[CH-]C.C[CH-]C.C[CH-]C.C[CH-]C PXDRFTPXHTVDFR-UHFFFAOYSA-N 0.000 abstract description 3
- 238000004508 fractional distillation Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 239000004593 Epoxy Substances 0.000 abstract 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000001294 propane Substances 0.000 abstract 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 abstract 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 239000000047 product Substances 0.000 description 11
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 229910001385 heavy metal Inorganic materials 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- -1 quaternary ammonium salt cation Chemical class 0.000 description 3
- OSDWBNJEKMUWAV-UHFFFAOYSA-N Allyl chloride Chemical compound ClCC=C OSDWBNJEKMUWAV-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- VZHHNBNSMNNUAD-UHFFFAOYSA-N cobalt 2-[2-[(2-hydroxyphenyl)methylideneamino]ethyliminomethyl]phenol Chemical compound [Co].OC1=CC=CC=C1C=NCCN=CC1=CC=CC=C1O VZHHNBNSMNNUAD-UHFFFAOYSA-N 0.000 description 2
- YSAVZVORKRDODB-WDSKDSINSA-N diethyl tartrate Chemical compound CCOC(=O)[C@@H](O)[C@H](O)C(=O)OCC YSAVZVORKRDODB-WDSKDSINSA-N 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- PTVWPYVOOKLBCG-CYBMUJFWSA-N (2r)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol Chemical compound C1CN(C[C@@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-CYBMUJFWSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003426 co-catalyst Substances 0.000 description 1
- 229910001429 cobalt ion Inorganic materials 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- ZUKDFIXDKRLHRB-UHFFFAOYSA-K cobalt(3+);triacetate Chemical compound [Co+3].CC([O-])=O.CC([O-])=O.CC([O-])=O ZUKDFIXDKRLHRB-UHFFFAOYSA-K 0.000 description 1
- 238000006735 epoxidation reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 229950008325 levothyroxine Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000005870 sharpless asymmetric epoxidation reaction Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/09—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
- C07C29/10—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
- C07C29/103—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
- C07C29/106—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers of oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
- C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
- C07D301/19—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic hydroperoxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
Abstract
本发明公开一种(R)‑3‑氯‑1,2‑丙二醇的制备方法,属于手性材料制备技术领域。该方法首先在氮气保护下,向反应容器中加入氯仿,先后向其中加入四异丙基氧钛和L(‑)‑酒石酸二乙酯,充分搅拌后滴加氯丙烯,然后向其中加入叔丁基过氧化氢后搅拌12小时,待反应完全后,减压蒸馏制得(S)‑3‑氯‑1,2‑环氧丙烷,将(S)‑3‑氯‑1,2‑环氧丙烷溶于蒸馏水中充分溶解后,向其中滴加相转移催化剂,搅拌加热至90℃,反应24h后,将碱液加入反应后的混合溶液中,调节pH值至7,将反应混合物通过减压分馏,制得目标产物(R)‑3‑氯‑1,2‑丙二醇。本发明所需原料廉价易得,制备成本较低;本发明方法流程简单,操作简便,产品的收率较高,有利于工业化推广。The invention discloses a preparation method of (R)-3-chloro-1,2-propanediol, and belongs to the technical field of chiral material preparation. The method firstly adds chloroform to a reaction vessel under nitrogen protection, successively adds tetraisopropyltitanium oxide and L(-)-diethyl tartrate, fully stirs and then adds chloropropene dropwise, and then adds tert-butyl After the reaction was completed, (S)-3-chloro-1,2-epoxy propylene was obtained by distillation under reduced pressure, and (S)-3-chloro-1,2-epoxy After the propane was dissolved in distilled water and fully dissolved, a phase transfer catalyst was added dropwise to it, and heated to 90°C with stirring. After 24 hours of reaction, the lye solution was added to the mixed solution after the reaction, and the pH value was adjusted to 7. The reaction mixture was decompressed. Fractional distillation to obtain the target product (R)-3-chloro-1,2-propanediol. The raw materials required by the invention are cheap and easy to obtain, and the preparation cost is low; the method of the invention has simple process flow, simple and convenient operation, high product yield, and is favorable for industrialization promotion.
Description
技术领域:Technical field:
本发明属于手性材料制备技术领域,特别涉及一种(R)-3-氯-1,2-丙二醇的制备方法。The invention belongs to the technical field of preparation of chiral materials, in particular to a preparation method of (R)-3-chloro-1,2-propanediol.
背景技术:Background technique:
(R)-3-氯-1,2-丙二醇为重要的医药中间体,可用来合成镇咳药左旋羟丙哌嗪。左旋羟丙哌嗪(Levodropopizine),化学名为S-(-)-3-(4-苯基-1-哌嗪基)-1,2-丙二醇,是一种新型镇咳药,研究表明其外消旋体R-(-)-3-(4-苯基-1-哌嗪基)-1,2-丙二醇在镇咳上具有同样效果,但副作用较大,尤其能使中枢神经产生不良反应。如果能将这对消旋体拆分开,那么这对具有光学活性对映体产品会有更好的药用效果,但是工业上拆分消旋体的成本很高,且难以实现产业化的推广。以(R)-3-氯-1,2-丙二醇合成左旋羟丙哌嗪的反应过程如下:(R)-3-Chloro-1,2-propanediol is an important pharmaceutical intermediate, which can be used to synthesize the antitussive drug L-hydroxypropanediol. Levodropopizine, with the chemical name of S-(-)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol, is a new antitussive. The racemate R-(-)-3-(4-phenyl-1-piperazinyl)-1,2-propanediol has the same effect in antitussive, but the side effects are larger, especially the central nervous system. reaction. If the pair of racemates can be separated, the pair of optically active enantiomer products will have better medicinal effects, but the cost of industrially separating the racemates is very high, and it is difficult to achieve industrialization. promotion. With (R)-3-chloro-1,2-propanediol, the reaction process of synthesizing L-Hydroxypropanediol is as follows:
目前生产(R)-3-氯-1,2-丙二醇的方法如下:The current method for producing (R)-3-chloro-1,2-propanediol is as follows:
该方法生产效率低,成本高,并且使用Salen-Co催化剂((R,R’)-(-)-N,N-双(3,5-二叔丁基亚水杨基)-1,2-环己基二胺醋酸钴(III)),(R)-3-氯-1,2-丙二醇中重金属离子严重超标,如果直接用来生产左旋羟丙哌嗪,那么会造成左旋羟丙哌嗪中重金属超标,达不到食品及医药级添加剂的标准要求,而如果再次对左旋羟丙哌嗪重结晶除去重金属离子,那么生产成本也会相应地大大增加。The method has low production efficiency and high cost, and uses a Salen-Co catalyst ((R,R')-(-)-N,N-bis(3,5-di-tert-butylsalicylidene)-1,2 - Cyclohexyldiamine acetate cobalt(III)), (R)-3-chloro-1,2-propanediol in heavy metal ions are seriously exceeding the standard. The heavy metals exceed the standard and fail to meet the standard requirements of food and pharmaceutical grade additives. If the heavy metal ions are removed by recrystallization of levothyroxine again, the production cost will also be greatly increased accordingly.
发明内容:Invention content:
本发明针对现有技术中存在的上述问题,提供一种(R)-3-氯-1,2-丙二醇的制备方法。该方法简单实用,无重金属钴离子的污染,同时所得到的(R)-3-氯-1,2-丙二醇具有收率高、手性纯度高、含水量低,具有良好的工业化推广价值。Aiming at the above-mentioned problems in the prior art, the present invention provides a preparation method of (R)-3-chloro-1,2-propanediol. The method is simple and practical, without the pollution of heavy metal cobalt ions, and the obtained (R)-3-chloro-1,2-propanediol has high yield, high chiral purity and low water content, and has good industrialization value.
本发明提供的一种(R)-3-氯-1,2-丙二醇的制备方法的具体步骤如下:The concrete steps of the preparation method of a kind of (R)-3-chloro-1,2-propanediol provided by the invention are as follows:
(1)(S)-3-氯-1,2-环氧丙烷的合成:(1) Synthesis of (S)-3-chloro-1,2-epoxypropane:
在氮气保护下,向反应容器中加入一定量的反应溶剂,在-10℃~0℃下,先后向其中加入四异丙基氧钛和L(-)-酒石酸二乙酯((-)DET),充分搅拌后向其中滴加氯丙烯,待滴加完毕充分混合后向其中加入叔丁基过氧化氢,将所得混合溶液搅拌12小时,用TLC(薄层色谱)或HPLC(高效液相色谱)监测反应进程,待反应完全后,减压蒸馏并分馏出产物,得(S)-3-氯-1,2-环氧丙烷。Under nitrogen protection, a certain amount of reaction solvent was added to the reaction vessel, and at -10°C to 0°C, tetraisopropyl titanium oxide and L(-)-diethyl tartrate ((-)DET were added successively to it ), add chloropropene dropwise to it after fully stirring, add tert-butyl hydroperoxide to it after fully mixing after the dropwise addition, stir the gained mixed solution for 12 hours, use TLC (thin layer chromatography) or HPLC (high performance liquid phase) Chromatography) to monitor the reaction progress, after the reaction is complete, the product is distilled under reduced pressure and fractionated to obtain (S)-3-chloro-1,2-epoxypropane.
所述反应溶剂为氯仿,所述氯丙烯、四异丙基氧钛、L(-)-酒石酸二乙酯及所述叔丁基过氧化氢的摩尔比为:氯丙烯∶四异丙基氧钛∶L(-)-酒石酸二乙酯∶叔丁基过氧化氢=1∶1∶1∶1.5~2.5;减压蒸馏温度为60~65℃,压力-0.08MPa;本步骤中Sharpless不对称环氧化反应溶剂为氯仿,所用氧化剂为叔丁基过氧化氢。The reaction solvent is chloroform, and the molar ratio of the allyl chloride, tetraisopropyl titanium oxide, L(-)-diethyl tartrate and the tert-butyl hydroperoxide is: allyl chloride: tetraisopropyl oxygen Titanium: L(-)-diethyl tartrate: tert-butyl hydroperoxide=1:1:1:1.5~2.5; vacuum distillation temperature is 60~65℃, pressure is -0.08MPa; Sharpless is asymmetric in this step The epoxidation reaction solvent is chloroform, and the oxidant used is tert-butyl hydroperoxide.
(2)(R)-3-氯-1,2-丙二醇的合成:(2) Synthesis of (R)-3-chloro-1,2-propanediol:
在氮气保护下,将步骤(1)得到的(S)-3-氯-1,2-环氧丙烷溶于一定量蒸馏水中,充分溶解后,向其中滴加相转移催化剂的水溶液,搅拌加热至90℃,反应24h,TLC或HPLC监测反应进程,待反应完成后,将碱液加入反应后的混合溶液中,调节pH值至7,调节完毕后停止反应,将反应混合物通过减压分馏,分离出水分和产物(R)-3-氯-1,2-丙二醇。Under nitrogen protection, (S)-3-chloro-1,2-epoxypropane obtained in step (1) was dissolved in a certain amount of distilled water, and after fully dissolving, an aqueous solution of phase transfer catalyst was added dropwise thereto, and heated with stirring. to 90°C, react for 24 hours, monitor the reaction progress by TLC or HPLC, after the reaction is completed, add the lye solution to the mixed solution after the reaction, adjust the pH value to 7, stop the reaction after the adjustment, and pass the reaction mixture through fractional distillation under reduced pressure, Moisture and product (R)-3-chloro-1,2-propanediol were separated off.
所述相转移催化剂为四正丁基硫酸氢铵,在水中硫酸氢根可电离出H+参与催化反应,季铵盐阳离子可使有机相与水中的阴离子发生相转移,加快反应速率;反应物摩尔比:(S)-3-氯-1,2-环氧丙烷∶四正丁基硫酸氢铵=100∶1~3;所述减压蒸馏温度为60~65℃,压力为-0.08MPa。The phase transfer catalyst is tetra-n-butyl ammonium hydrogen sulfate. In water, hydrogen sulfate can ionize H + to participate in the catalytic reaction, and the quaternary ammonium salt cation can cause phase transfer between the organic phase and the anions in the water to speed up the reaction rate; the reactants Molar ratio: (S)-3-chloro-1,2-epoxypropane: tetra-n-butylammonium hydrogen sulfate=100: 1~3; the vacuum distillation temperature is 60~65℃, and the pressure is -0.08MPa .
其反应过程如下:The reaction process is as follows:
本发明具有以下技术特点:The present invention has the following technical characteristics:
1、采用廉价易得的氯丙烯为起始原料,生产成本更低。1. Using cheap and readily available chloropropene as the starting material, the production cost is lower.
2、充分利用Sharpless不对称环氧化,能得到高产率的左旋或右旋的对映体产品,本方面主要合成右旋的中间产物。2. By making full use of Sharpless asymmetric epoxidation, high-yield levorotatory or dextrorotatory enantiomer products can be obtained. In this aspect, dextrorotatory intermediate products are mainly synthesized.
3、与传统催化剂Salen-Co相比,采用酸性相转移催化剂,一方面起到相转移催化效果,另一方面在酸性介质中转化率高,并且解决了产品重金属离子含量超标的问题。3. Compared with the traditional catalyst Salen-Co, the use of an acidic phase transfer catalyst, on the one hand, has a phase transfer catalytic effect, on the other hand, the conversion rate is high in an acidic medium, and the problem of excessive heavy metal ion content in the product is solved.
4、收率高易分离与纯化,手性纯度高,附加值高。4. High yield, easy separation and purification, high chiral purity and high added value.
具体实施方式:Detailed ways:
实施例1:本发明提供的(R)-3-氯-1,2-丙二醇的制备方法具体步骤如下:Embodiment 1: the specific steps of the preparation method of (R)-3-chloro-1,2-propanediol provided by the invention are as follows:
(1)(S)-3-氯-1,2-环氧丙烷的制备:(1) Preparation of (S)-3-chloro-1,2-epoxypropane:
在-10℃下,将30mL氯仿加入到100mL三颈圆底烧瓶中,先后加入0.344mL(0.412g,2mmol)的L(-)酒石酸二乙酯,0.594mL(2mmol)的四丙基氧钛,充分搅拌后,加入0.153g(2mmol)氯丙烯,搅拌10min后加入0.391mL(0.36g,4mmol)叔丁基过氧化氢,将所得的混合溶液在-10~0℃的冰箱内搅拌12小时,反应期间通过TLC或HPLC监测反应进程,待反应完全后,65℃(-0.08MPa)下分馏出产物,得纯品。收率90.4%,纯度:99.3%,手性纯度:99.5%e.e。At -10°C, 30 mL of chloroform was added to a 100 mL three-necked round-bottomed flask, followed by 0.344 mL (0.412 g, 2 mmol) of L(-) diethyl tartrate, 0.594 mL (2 mmol) of tetrapropyl titanium oxide , after fully stirring, add 0.153g (2mmol) chloropropene, stir for 10min, add 0.391mL (0.36g, 4mmol) tert-butyl hydroperoxide, stir the resulting mixed solution in a refrigerator at -10~0℃ for 12 hours During the reaction, the reaction progress was monitored by TLC or HPLC. After the reaction was completed, the product was fractionated at 65°C (-0.08MPa) to obtain pure product. Yield 90.4%, purity: 99.3%, chiral purity: 99.5% e.e.
(2)(R)-3-氯-1,2-丙二醇的制备:(2) Preparation of (R)-3-chloro-1,2-propanediol:
在50mL的三口烧瓶中加入20mL蒸馏水、纯品(S)-3-氯-1,2-环氧丙烷0.78mL(0.92g,10mmol),充分混合后向混合溶液加入3.4mg四正丁基硫酸氢铵,搅拌加热至90℃,反应24小时,TLC或HPLC监测反应进程,待反应完成后,0.1N氢氧化钠加入反应后的混合溶液中,调节pH至7,调节完毕后停止反应,60℃(-0.08MPa)下蒸馏过量的水,然后高真空-0.1MPa下蒸馏产品(R)-3-氯-1,2-丙二醇。收率96.4%,纯度:99.5%,手性纯度:99.7%e.e。In a 50 mL three-necked flask, add 20 mL of distilled water and 0.78 mL (0.92 g, 10 mmol) of pure (S)-3-chloro-1,2-epoxypropane, and after thorough mixing, add 3.4 mg of tetra-n-butyl sulfuric acid to the mixed solution Ammonium hydrogen, heated to 90°C with stirring, and reacted for 24 hours. TLC or HPLC was used to monitor the reaction progress. After the reaction was completed, 0.1N sodium hydroxide was added to the mixed solution after the reaction, and the pH was adjusted to 7. After the adjustment, the reaction was stopped, and 60 Excess water was distilled at °C (-0.08MPa), then the product (R)-3-chloro-1,2-propanediol was distilled at high vacuum -0.1MPa. Yield 96.4%, purity: 99.5%, chiral purity: 99.7% e.e.
实施例2:本发明提供的(R)-3-氯-1,2-丙二醇的制备方法具体步骤如下:Embodiment 2: the specific steps of the preparation method of (R)-3-chloro-1,2-propanediol provided by the invention are as follows:
(1)(S)-3-氯-1,2-环氧丙烷的制备(1) Preparation of (S)-3-chloro-1,2-epoxypropane
在-10℃下,将60mL氯仿加入到250mL三颈圆底烧瓶中,先后加入34.4mL(41.2g,0.2mol)的L(-)酒石酸二乙酯,59.4mL(0.2mol)的四丙基氧钛,充分搅拌后,加入15.3g(0.2mol)氯丙烯,搅拌10min后加入39.1mL(36g,0.4mol)叔丁基过氧化氢,将所得的混合溶液在-10~0℃的冰箱内搅拌12小时,反应期间通过TLC或HPLC监测反应进程,待反应完全后,65℃(-0.08MPa)下分馏出产物,得纯品。收率90.1%,纯度:98.8%,手性纯度:99.3%e.e。At -10 °C, 60 mL of chloroform was added to a 250 mL three-necked round-bottomed flask, followed by 34.4 mL (41.2 g, 0.2 mol) of L(-) diethyl tartrate and 59.4 mL (0.2 mol) of tetrapropyl tartrate. Titanium oxide, after fully stirring, add 15.3g (0.2mol) chloropropene, stir for 10min, add 39.1mL (36g, 0.4mol) tert-butyl hydroperoxide, put the resulting mixed solution in a refrigerator at -10~0℃ Stir for 12 hours. During the reaction, monitor the reaction progress by TLC or HPLC. After the reaction is complete, fractionate the product at 65°C (-0.08MPa) to obtain pure product. Yield 90.1%, purity: 98.8%, chiral purity: 99.3% e.e.
(2)(R)-3-氯-1,2-丙二醇的制备(2) Preparation of (R)-3-chloro-1,2-propanediol
在250mL的三口烧瓶中加入50mL蒸馏水、纯品(S)-3-氯-1,2-环氧丙烷78mL(92g,1mol),充分混合后向混合溶液滴加0.35g四正丁基硫酸氢铵水溶液,搅拌加热至90℃,反应24小时,TLC或HPLC监测反应进程,待反应完成后,0.1N氢氧化钠加入反应后的混合溶液中,调节pH至7,调节完毕后停止反应,60℃(-0.08MPa)下蒸馏过量的水,然后高真空-0.1MPa下蒸馏产品(R)-3-氯-1,2-丙二醇。收率95.9%,纯度:98.5%,手性纯度:99.6%e.e。Add 50 mL of distilled water and 78 mL (92 g, 1 mol) of pure (S)-3-chloro-1,2-epoxypropane to a 250 mL three-necked flask, mix thoroughly, and add 0.35 g of tetra-n-butyl hydrogen sulfate dropwise to the mixed solution Aqueous ammonium solution, heated to 90°C with stirring, and reacted for 24 hours. TLC or HPLC monitored the reaction progress. After the reaction was completed, 0.1N sodium hydroxide was added to the mixed solution after the reaction, and the pH was adjusted to 7. After the adjustment, the reaction was stopped, and 60 Excess water was distilled at °C (-0.08MPa), then the product (R)-3-chloro-1,2-propanediol was distilled at high vacuum -0.1MPa. Yield 95.9%, purity: 98.5%, chiral purity: 99.6% e.e.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010971610.1A CN111943805A (en) | 2020-09-16 | 2020-09-16 | Preparation method of (R) -3-chloro-1, 2-propanediol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010971610.1A CN111943805A (en) | 2020-09-16 | 2020-09-16 | Preparation method of (R) -3-chloro-1, 2-propanediol |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111943805A true CN111943805A (en) | 2020-11-17 |
Family
ID=73357308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010971610.1A Pending CN111943805A (en) | 2020-09-16 | 2020-09-16 | Preparation method of (R) -3-chloro-1, 2-propanediol |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111943805A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113943206A (en) * | 2021-10-25 | 2022-01-18 | 华今(山东)新材料科技有限公司 | Preparation method of high-quality (R) -3-chloro-1, 2-propanediol |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1680565A (en) * | 2005-02-05 | 2005-10-12 | 上海科利生物医药有限公司 | Preparation of chiral epichlorohydrin |
WO2008128013A1 (en) * | 2007-04-12 | 2008-10-23 | Dow Global Technologies Inc. | Process and apparatus for azeotropic recovery of dichlorohydrins |
CN102229523A (en) * | 2011-05-25 | 2011-11-02 | 张中法 | Preparation method of 3-chloro-1,2-propanediol |
CN104277027A (en) * | 2014-09-24 | 2015-01-14 | 扬州三友合成化工有限公司 | Preparation method of (R)-propylene carbonate |
CN104844421A (en) * | 2015-04-27 | 2015-08-19 | 芜湖福民生物药业有限公司 | Preparation method for (R)-3-chloro-1,2-propanediol |
CN106187678A (en) * | 2016-07-07 | 2016-12-07 | 上海科利生物医药有限公司 | A kind of preparation method of (R) 3 chlorine 1,2 propylene glycol |
CN109867587A (en) * | 2017-12-01 | 2019-06-11 | 中国科学院大连化学物理研究所 | A kind of preparation method of 3 chloro- 1,2- propylene glycol |
-
2020
- 2020-09-16 CN CN202010971610.1A patent/CN111943805A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1680565A (en) * | 2005-02-05 | 2005-10-12 | 上海科利生物医药有限公司 | Preparation of chiral epichlorohydrin |
WO2008128013A1 (en) * | 2007-04-12 | 2008-10-23 | Dow Global Technologies Inc. | Process and apparatus for azeotropic recovery of dichlorohydrins |
CN102229523A (en) * | 2011-05-25 | 2011-11-02 | 张中法 | Preparation method of 3-chloro-1,2-propanediol |
CN104277027A (en) * | 2014-09-24 | 2015-01-14 | 扬州三友合成化工有限公司 | Preparation method of (R)-propylene carbonate |
CN104844421A (en) * | 2015-04-27 | 2015-08-19 | 芜湖福民生物药业有限公司 | Preparation method for (R)-3-chloro-1,2-propanediol |
CN106187678A (en) * | 2016-07-07 | 2016-12-07 | 上海科利生物医药有限公司 | A kind of preparation method of (R) 3 chlorine 1,2 propylene glycol |
CN109867587A (en) * | 2017-12-01 | 2019-06-11 | 中国科学院大连化学物理研究所 | A kind of preparation method of 3 chloro- 1,2- propylene glycol |
Non-Patent Citations (6)
Title |
---|
SOFIA BARLUENGA等: "Modular Asymmetric Synthesis of Aigialomycin D, a Kinase-Inhibitory Scaffold", 《ANGEW. CHEM. INT. ED.》 * |
吕耀宏: "3-氯-1,2-丙二醇的合成工艺优化", 《浙江化工》 * |
姚其正主编: "《药物合成反应》", 31 December 2019, 中国医药科技出版社 * |
沈大冬等: "(R)-3-氯-1,2-丙二醇及镇咳药左羟丙哌嗪的合成", 《中国药物化学杂志》 * |
王沛主编: "《制药工艺学》", 31 August 2017, 中国中医药出版社 * |
王燕等: "(S)-和(R)-普萘洛尔的不对称合成", 《有机化学》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113943206A (en) * | 2021-10-25 | 2022-01-18 | 华今(山东)新材料科技有限公司 | Preparation method of high-quality (R) -3-chloro-1, 2-propanediol |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110078684B (en) | Method for continuously synthesizing epichlorohydrin by using microchannel reactor | |
CN113527188A (en) | Method for preparing meta-functionalized pyridine compound | |
CN113214258A (en) | Method and device for synthesizing diquat dichloride | |
CN114181191A (en) | Synthetic method of cyclic sulfate | |
CN111943805A (en) | Preparation method of (R) -3-chloro-1, 2-propanediol | |
CN107814939A (en) | A kind of method that metal oxide oxidation catalyst synthesizes poly- methylphosphonic acid glycol ester | |
CN114605332B (en) | Preparation process of metronidazole | |
CN106892807B (en) | A kind of preparation method of the isophorone using organic imidazoles system quaternary ammonium strong base catalyst | |
CN115850087A (en) | Method for preparing N, N-dimethylbenzylamine | |
CN115028584A (en) | Ionic liquid for producing glutaraldehyde | |
CN104610064B (en) | One-pot method using carbonate as a catalyst for the preparation of dimethyl carbonate | |
CN113563166B (en) | Synthesis method of vanillyl alcohol ether | |
CN108727173A (en) | The method for preparing 1,1,3- trichloroacetones | |
CN112225653A (en) | Green synthesis method of natural benzaldehyde | |
CN112480059A (en) | Method for directly synthesizing cyclic carbonate from olefin under catalysis of metalloporphyrin | |
CN115557832B (en) | Synthesis method of citronellal | |
CN112209847A (en) | Method for preparing amide compound under catalysis of ionic liquid in high-pressure environment | |
CN116041279B (en) | A method for preparing piperidine using an autoclave device and a ruthenium-containing catalyst | |
CN110563586A (en) | Method for preparing dimethyl carbonate in one pot under low pressure condition | |
CN116041278B (en) | Method for preparing piperidine by using micro-reactor device and ruthenium-containing catalyst | |
CN115403461B (en) | A method for oxidizing ethylbenzene to synthesize benzoic acid | |
CN117285402B (en) | A preparation method of pregabalin intermediate | |
CN110724064B (en) | Method for synthesizing 2-cyclohexane substituted benzamide under catalysis of nickel | |
CN116354887B (en) | A biimidazole amino acid ionic liquid and its preparation method and application | |
CN114671729B (en) | Preparation method of aromatic ethylamine and derivative thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201117 |
|
RJ01 | Rejection of invention patent application after publication |